16 results on '"DeMeo MT"'
Search Results
2. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern.
- Author
-
Rose DJ, DeMeo MT, Keshavarzian A, and Hamaker BR
- Published
- 2007
3. Pancreatic cancer and sugar diabetes.
- Author
-
DeMeo MT
- Published
- 2001
4. Nutrition grand rounds. Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases.
- Author
-
DeMeo MT, Mobarhan S, Mikolaitis S, and Kazi N
- Published
- 1997
5. Introduction.
- Author
-
McClave SA and DeMeo MT
- Published
- 2002
- Full Text
- View/download PDF
6. North American Summit on Aspiration in the Critically Ill Patient: consensus statement.
- Author
-
McClave SA, DeMeo MT, DeLegge MH, DiSario JA, Heyland DK, Maloney JP, Metheny NA, Moore FA, Scolapio JS, Spain DA, Zaloga GP, McClave, Stephen A, DeMeo, Mark T, DeLegge, Mark H, DiSario, James A, Heyland, Daren K, Maloney, James P, Metheny, Norma A, Moore, Frederick A, and Scolapio, James S
- Published
- 2002
- Full Text
- View/download PDF
7. The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota Compartments.
- Author
-
Shobar RM, Velineni S, Keshavarzian A, Swanson G, DeMeo MT, Melson JE, Losurdo J, Engen PA, Sun Y, Koenig L, and Mutlu EA
- Abstract
Objectives: Bowel preparations (BPs) taken before colonoscopy may introduce a confounding effect on the results of gastrointestinal microbiota studies. This study aimed to determine the effect of bowel preparation on the mucosa-associated and luminal colonic microbiota in healthy subjects (HC) and inflammatory bowel disease (IBD) patients., Methods: Biopsy samples (n=36) and fecal samples (n=30) were collected from 10 HC and 8 IBD subjects pre- and post-BP. 16S rRNA gene was pyrosequenced using 454 Titanium protocols. We compared the differences between the pre- and post-BP samples (i.e., comparisons-across-bowel-prep); we examined the effect of BP on the expected separation of the mucosal vs. the luminal compartments (i.e., comparisons-across-compartments). Last, we compared the baseline differences between the HC vs. IBD groups (a secondary analysis), and examined whether the differences between the HC vs. IBD changed after BP., Results: In comparisons-across-bowel-prep, the Shannon's index (SI) decreased only in the biopsy samples of IBD subjects post-BP (P=0.025) and phylogenetic diversity-whole tree (PD-WT) metric decreased in biopsy samples of HC subjects post-BP (P=0.021). In secondary comparisons, the subtle differences between the fecal samples of the HC vs. IBD groups, in terms of evenness and the SI, were not apparent post-BP. In terms of β-diversity, in comparisons-across-bowel-prep, the proportion of shared operational taxonomic units (OTUs) in pre- and post-BP samples was low (~30%) and unweighted Unifrac distances between pre- and post-BP specimens ranged from 0.52 to 0.66. HC biopsies were affected more than IBD biopsies with BP (P=0.004). In comparisons-across-compartments, the proportion of shared OTUs between biopsy and fecal samples increased and Unifrac distances decreased post-BP in IBD subjects, reducing the differences between the mucosal and luminal compartments of the gut microbiota. Interindividual differences in Unifrac distances were preserved even with BP effects, although the effects were greater on weighted Unifrac distances. Bacteroidetes and its subtypes increased post-BP in both the luminal and mucosal compartments., Conclusions: Bowel preparations affect the composition and diversity of the fecal and luminal microbiota in the short term, introducing potential bias into experiments examining the gut microbiota. The magnitude of the effect of BP is not greater than that of interindividual variation. Both the luminal and mucosal compartments of the gut microbiota get affected, and samples from controls and IBD subjects may get affected differently. Studies of the colonic microbiota should take into account the direction and the magnitude of the change introduced by BP during the design stage of the experiments, and consider sample sizes so that potential bias is minimized.
- Published
- 2016
- Full Text
- View/download PDF
8. In vitro evaluation of intestinal epithelial TLR activation in preventing food allergic responses.
- Author
-
de Kivit S, Tobin MC, DeMeo MT, Fox S, Garssen J, Forsyth CB, Keshavarzian A, and Landay AL
- Subjects
- Adult, Aged, Cell Line, Tumor, Coculture Techniques, Female, Food Hypersensitivity immunology, Food Hypersensitivity metabolism, Gene Expression Regulation immunology, Humans, Male, Middle Aged, Toll-Like Receptors immunology, Young Adult, Epithelial Cells immunology, Epithelial Cells metabolism, Food Hypersensitivity prevention & control, Intestinal Mucosa cytology, Leukocytes, Mononuclear metabolism, Toll-Like Receptors metabolism
- Abstract
Alterations in the gut microbiota composition are associated with food allergy. Toll-like receptors (TLRs) respond to microbial stimuli. We studied the effects of the ligation of TLRs on intestinal epithelial cells (IECs) in preventing an allergic effector response. IEC monolayers (T84 cells) were co-cultured with CD3/28-activated PBMCs from healthy controls or atopic patients and simultaneously apically exposed to TLR2, TLR4 or TLR9 ligands. The barrier integrity of T84 cell monolayers was significantly reduced upon co-culture with PBMCs of food allergic subjects compared to healthy subjects. Apical exposure of IECs to a TLR9 ligand prevented PBMC-induced epithelial barrier disruption. Using PBMCs from food allergic subjects, apical TLR9 activation on IECs increased the IFN-γ/IL-13 and IL-10/IL-13 ratio, while suppressing pro-inflammatory IL-6, IL-8 and TNF-α production in an IEC-dependent manner. Hence, the activation of apical TLR9 on IECs, potentially by microbiota-derived signals, may play an important role in the prevention of allergic inflammation., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
9. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2).
- Author
-
Whitcomb DC, Yadav D, Adam S, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lo SK, DeMeo MT, Steinberg WM, Kochman ML, Etemad B, Forsmark CE, Elinoff B, Greer JB, O'Connell M, Lamb J, and Barmada MM
- Subjects
- Acute Disease, Case-Control Studies, Female, Humans, Male, Recurrence, Risk Factors, Surveys and Questionnaires, United States, Pancreatitis, Chronic etiology
- Abstract
Background: Recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP) are complex syndromes associated with numerous etiologies, clinical variables and complications. We developed the North American Pancreatitis Study 2 (NAPS2) to be sufficiently powered to understand the complex environmental, metabolic and genetic mechanisms underlying RAP and CP., Methods: Between August 2000 and September 2006, a consortium of 20 expert academic and private sites prospectively ascertained 1,000 human subjects with RAP or CP, plus 695 controls (spouse, family, friend or unrelated). Standardized questionnaires were completed by both the physicians and study subjects and blood was drawn for genomic DNA and biomarker studies. All data were double-entered into a database and systematically reviewed to minimize errors and include missing data., Results: A total of 1,000 subjects (460 RAP, 540 CP) and 695 controls who completed consent forms and questionnaires and donated blood samples comprised the final dataset. Data were organized according to diagnosis, supporting documentation, etiological classification, clinical signs and symptoms (including pain patterns and duration, and quality of life), past medical history, family history, environmental exposures (including alcohol and tobacco use), medication use and therapeutic interventions. Upon achieving the target enrollment, data were organized and classified to facilitate future analysis. The approaches, rationale and datasets are described, along with final demographic results., Conclusion: The NAPS2 consortium has successfully completed a prospective ascertainment of 1,000 subjects with RAP and CP from the USA. These data will be useful in elucidating the environmental, metabolic and genetic conditions, and to investigate the complex interactions that underlie RAP and CP., (Copyright 2008 S. Karger AG, Basel.)
- Published
- 2008
- Full Text
- View/download PDF
10. Physiology of the aerodigestive system and aberrations in that system resulting in aspiration.
- Author
-
DeMeo MT and Bruninga K
- Subjects
- Humans, Digestive System physiopathology, Digestive System Diseases physiopathology, Inhalation physiology, Pneumonia, Aspiration etiology
- Abstract
Background: Aspiration pneumonia remains a significant and often devastating problem in critically ill patients. It is unclear whether aspiration pneumonia occurs because of problems in the handling of oropharyngeal secretions or if the reflux of gastric contents is the major etiological factor. Additionally, the obvious breakdown of upper aerodigestive protective mechanisms in the critically ill patient population is largely unstudied. Finally, the impact and contribution of tubes, both endotracheal and nasoenteral, on aspiration pneumonia is unclear., Methods: A Medline literature search on scientific and review articles concerning the normal physiology of the aerodigestive tract and factors that compromised normal physiology was undertaken. Readings were supplemented by expert outside opinion from researchers in these fields and from the combined expertise from a multidisciplinary panel of experts assembled at a recent summit on aspiration pneumonia., Results: Changes in the normal physiology of the aerodigestive tract are vast and varied and dependent on the response to injury, iatrogenic interventions, and the use of nasoenteral and endotracheal tubes. The effects on gastric and esophageal motility are likely dynamic and represent an ongoing but changing risk of reflux for the patient. Nasoenteral and endotracheal tubes likely compromise upper aerodigestive protective mechanisms., Conclusions: More research is needed on the functioning of the aerodigestive protective mechanisms in critically ill patients. Understanding of the dynamic changes in gastrointestinal motility will also be an important factor to decrease the incidence of aspiration pneumonia in this patient population.
- Published
- 2002
- Full Text
- View/download PDF
11. Acute pancreatitis in children.
- Author
-
DeBanto JR, Goday PS, Pedroso MR, Iftikhar R, Fazel A, Nayyar S, Conwell DL, Demeo MT, Burton FR, Whitcomb DC, Ulrich CD 2nd, and Gates LK Jr
- Subjects
- Acute Disease, Adolescent, Child, Child, Preschool, Humans, Infant, Predictive Value of Tests, Prognosis, Sensitivity and Specificity, Pancreatitis diagnosis, Pancreatitis etiology
- Abstract
Objectives: Currently, there is no scoring system for predicting severity in acute pancreatitis in children. Our intent was to evaluate the performance of existing scoring systems in children, to develop a system for children, and to examine the etiology of acute pancreatitis in children., Methods: A chart review of children with acute pancreatitis was conducted at six centers, three serving as criterion centers and three as validation centers. Ranson and Glasgow scores were calculated for each admission. Additional clinical data were collected, and parameters correlating with severity were incorporated into a new scoring system. Performance characteristics were calculated for each system., Results: A total of 301 admissions were reviewed, 202 in the criterion group and 99 in the validation group. Eight parameters were included in a new scoring system for children. The parameters were as follows: age (<7 yr), weight (<23 kg), admission WBC (>18,500), admission LDH (>2,000), 48-h trough Ca2+ (<8.3 mg/dl), 48-h trough albumin (<2.6 g/dl), 48-h fluid sequestration (>75 ml/ kg/48 h), and 48-h rise in BUN (>5 mg/dl). When the cut-off for predicting a severe outcome was set at 3 criteria, the new system had better sensitivity versus Ranson and Glasgow scores (70% vs 30% and 35%, respectively) and a better negative predictive value (91% vs 85% and 85%). The specificity (79% vs 94% and 94%) and positive predictive value (45% vs 57% and 61%) fell slightly., Conclusion: The new scoring system performs better in this group than do existing systems.
- Published
- 2002
- Full Text
- View/download PDF
12. Intestinal permeation and gastrointestinal disease.
- Author
-
DeMeo MT, Mutlu EA, Keshavarzian A, and Tobin MC
- Subjects
- Acute Disease, Digestive System enzymology, Digestive System immunology, Food Hypersensitivity metabolism, Gastric Acid metabolism, Humans, Hydrogen-Ion Concentration, Liver Diseases metabolism, Permeability, Celiac Disease metabolism, Crohn Disease metabolism, Digestive System metabolism, Pancreatitis metabolism
- Abstract
The gastrointestinal tract constitutes one of the largest sites of exposure to the outside environment. The function of the gastrointestinal tract in monitoring and sealing the host interior from intruders is called the gut barrier. A variety of specific and nonspecific mechanisms are in operation to establish the host barrier; these include luminal mechanisms and digestive enzymes, the epithelial cells together with tight junctions in between them, and the gut immune system. Disruptions in the gut barrier follow injury from various causes including nonsteroidal anti-inflammatory drugs and oxidant stress, and involve mechanisms such as adenosine triphosphate depletion and damage to epithelial cell cytoskeletons that regulate tight junctions. Ample evidence links gut barrier dysfunction to multiorgan system failure in sepsis and immune dysregulation. Additionally, contribution of gut barrier dysfunction to gastrointestinal disease is an evolving concept and is the focus of this review. An overview of the evidence for the role of gut barrier dysfunction in disorders such as Crohn's disease, celiac disease, food allergy, acute pancreatitis, non-alcoholic fatty liver disease, and alcoholic liver disease is provided, together with critical insight into the implications of this evidence as a primary disease mechanism.
- Published
- 2002
- Full Text
- View/download PDF
13. Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases.
- Author
-
DeMeo MT, Mobarhan S, Mikolaitis S, and Kazi N
- Subjects
- Adult, Aged, Appetite Depressants adverse effects, Diabetes Mellitus, Type 2 etiology, Diabetes Mellitus, Type 2 therapy, Fatty Liver etiology, Fatty Liver therapy, Female, Fenfluramine adverse effects, Fenfluramine therapeutic use, Hepatitis etiology, Hepatitis therapy, Humans, Male, Obesity diet therapy, Phentermine adverse effects, Phentermine therapeutic use, Sleep Apnea Syndromes etiology, Sleep Apnea Syndromes therapy, Appetite Depressants therapeutic use, Diet, Reducing, Obesity complications, Obesity therapy
- Abstract
The effect of weight loss with anorectic medications on sleep apnea, non-insulin-dependent diabetes, and steatohepatitis is illustrated in three cases from practice in a clinical nutrition setting. Prevention of obesity, a chronic disorder, is preferable, but when obesity becomes a major obstacle in the care of patients with respiratory, cardiovascular, and metabolic disorders and osteoarthritis, an intense course of weight reduction using anorectic medications under medical and dietetic guidance is essential for patients' survival and reduction of medical cost.
- Published
- 1997
- Full Text
- View/download PDF
14. Nutrition in acute pulmonary disease.
- Author
-
DeMeo MT, Van de Graaff W, Gottlieb K, Sobotka P, and Mobarhan S
- Subjects
- Acute Disease, Amino Acids administration & dosage, Dietary Carbohydrates administration & dosage, Dietary Fats administration & dosage, Humans, Lung immunology, Lung physiopathology, Nutritional Status, Respiratory Muscles physiopathology, Lung Diseases physiopathology, Nutritional Physiological Phenomena
- Abstract
Acutely stressed patients with chronic pulmonary disease have a particular need for accurate nutritional assessment and appropriate nutritional therapy. Loss of skeletal muscle, often extensive, can be paralleled by dramatic alterations in cellular function; inadvertent provision of excessive calories or of individual substrates may produce more harm than benefit. In the absence of a single "gold standard" for nutritional assessment and monitoring, no single value should take precedence over the entire clinical picture, which should be thoughtfully assessed and reassessed, with both the patient's nutritional needs and the consequences of their provision kept in mind. In the future, assessments of the impact of nutritional intervention will probably rely more heavily on functional tests of specific organs and of the immune system. Intervention will be based not only on provision of calories, individual substrates, vitamins, and minerals, but also on control of the inflammatory response in order that the nutrients may be properly utilized.
- Published
- 1992
- Full Text
- View/download PDF
15. The hazards of hypercaloric nutritional support in respiratory disease.
- Author
-
DeMeo MT, Mobarhan S, and Van De Graaff W
- Subjects
- Adult, Humans, Male, Proteins administration & dosage, Respiration, Artificial, Ventilator Weaning, Energy Intake, Parenteral Nutrition, Total adverse effects, Respiratory Tract Diseases therapy
- Abstract
This case illustrates the dangers of hypercaloric feeding in a patient with limited respiratory reserve, in this instance secondary to heart-lung transplantation. The patient's postoperative course was complicated by repeated bouts of infection and/or rejection that resulted in intubation and ventilatory support. The excessive caloric and protein load given to the patient resulted in increased CO2 generation with subsequent inability to wean the patient off the ventilator. Recognition of the problem and appropriate decreases in substrate intake permitted extubation.
- Published
- 1991
- Full Text
- View/download PDF
16. Erythromycin in chronic intestinal pseudo-obstruction.
- Author
-
Berger SA, Keshavarzian A, DeMeo MT, and Mobarhan S
- Subjects
- Adult, Chronic Disease, Female, Gastrointestinal Motility, Humans, Erythromycin therapeutic use, Intestinal Pseudo-Obstruction drug therapy
- Published
- 1990
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.